Literature DB >> 20805390

Mathematical modeling to characterize the inoculum effect.

Pratik Bhagunde1, Kai-Tai Chang, Renu Singh, Vandana Singh, Kevin W Garey, Michael Nikolaou, Vincent H Tam.   

Abstract

Killing by beta-lactams is well known to be reduced against a dense bacterial population, commonly known as the inoculum effect. However, the underlying mechanism of this phenomenon is not well understood. We proposed a semi-mechanistic mathematical model to account for the reduced in vitro killing observed. Time-kill studies were performed with 4 baseline inocula (ranging from approximately 1 × 10(5) to 1 × 10(8) CFU/ml) of Escherichia coli ATCC 25922 (MIC, 2 mg/liter). Constant but escalating piperacillin concentrations used ranged from 0.25× to 256× MIC. Serial samples were taken over 24 h to quantify viable bacterial burden, and all the killing profiles were mathematically modeled. The inoculum effect was attributed to a reduction of effective drug concentration available for bacterial killing, which was expressed as a function of the baseline inoculum. Biomasses associated with different inocula were examined using a colorimetric method. Despite identical drug-pathogen combinations, the baseline inoculum had a significant impact on bacterial killing. Our proposed mathematical model was unbiased and reasonable in capturing all 28 killing profiles collectively (r(2) = 0.88). Biomass was found to be significantly more after 24 h with a baseline inoculum of 1 × 10(8) CFU/ml, compared to one where the initial inoculum was 1 × 10(5) CFU/ml (P = 0.002). Our results corroborated previous observations that in vitro killing by piperacillin was significantly reduced against a dense bacterial inoculum. This phenomenon can be reasonably captured by our proposed mathematical model, and it may improve prediction of bacterial response to various drug exposures in future investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805390      PMCID: PMC2976129          DOI: 10.1128/AAC.01831-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases.

Authors:  B Bedenić; N Beader; Z Zagar
Journal:  Clin Microbiol Infect       Date:  2001-11       Impact factor: 8.067

2.  Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin.

Authors:  Alison K Meagher; Alan Forrest; Axel Dalhoff; Heino Stass; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

Authors:  Jeffrey J Campion; Patrick J McNamara; Martin E Evans
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics.

Authors:  C König; H P Simmen; J Blaser
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

5.  Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics.

Authors:  Y Yano; T Oguma; H Nagata; S Sasaki
Journal:  J Pharm Sci       Date:  1998-10       Impact factor: 3.534

6.  Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.

Authors:  Ping Liu; Kenneth H Rand; Bernd Obermann; Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2005-02       Impact factor: 5.283

7.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin.

Authors:  B D Hoyle; J Alcantara; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.

Authors:  D L Stevens; S Yan; A E Bryant
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

10.  Killing of Escherichia coli by beta-lactams at different inocula.

Authors:  Vincent H Tam; Kimberly R Ledesma; Kai-Tai Chang; Tsai-Ying Wang; John P Quinn
Journal:  Diagn Microbiol Infect Dis       Date:  2009-03-21       Impact factor: 2.803

View more
  5 in total

1.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

2.  Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer.

Authors:  Joel S Brown; Jessica J Cunningham; Robert A Gatenby
Journal:  IEEE Trans Biomed Eng       Date:  2016-11-01       Impact factor: 4.538

3.  A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B In Vitro.

Authors:  Grace Akrong; Alexia Chauzy; Vincent Aranzana-Climent; Mathilde Lacroix; Luc Deroche; Laure Prouvensier; Julien M Buyck; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

4.  Development of an in vitro Assay, Based on the BioFilm Ring Test®, for Rapid Profiling of Biofilm-Growing Bacteria.

Authors:  Enea G Di Domenico; Luigi Toma; Christian Provot; Fiorentina Ascenzioni; Isabella Sperduti; Grazia Prignano; Maria T Gallo; Fulvia Pimpinelli; Valentina Bordignon; Thierry Bernardi; Fabrizio Ensoli
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

5.  Optimization of E. coli Inactivation by Benzalkonium Chloride Reveals the Importance of Quantifying the Inoculum Effect on Chemical Disinfection.

Authors:  Míriam R García; Marta L Cabo
Journal:  Front Microbiol       Date:  2018-06-26       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.